This article summarizes insights from a 2025 MAPS Roundtable where Medical Affairs leaders discussed emerging trends in digital engagement, focusing on the rise of Digital Opinion Leaders (DOLs) and strategies for Healthcare Professional (HCP) influence mapping. The conversation highlighted how innovative approaches are reshaping disease awareness and stakeholder relationships.
Is Bluesky the new Twitter (X) for academic research conversations? Learn how Medical Affairs teams can maximize the opportunity of this new platform.
Pharma launch plans often overlook a critical driver of success: a formal insights strategy.
In what is certainly a new high or a new low for this podcast, we explore how to calculate the “Kardashian Index” of your KOLs and scientific leaders.
In this On-Demand webinar, you will focus on key learnings from the pilot and explore expansion in usage of this emerging technology.
The objective of this article is to discuss the paradigm shift in how companies plan for and deliver on the “long tail” of a drug’s impact even after Loss of Exclusivity (LoE) – a process known as lifecycle management (LCM).
In this On-Demand webinar, you will discover how to view a demo on the use of GenAI in data fact validation, learn key lessons in implementing GenAI-based medical and regulatory checks, explore how to address potential gaps and identify opportunities to scale.
In this webinar, we will share how to realize the potential of insights starts with a focus on strategy